Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 28841-28850 Newer>

The Motley Fool February 25, 2008 David Lee Smith	Chesapeake Drills On With its share price up 50% in a year, there may be lots more left in Chesapeake.
The Motley Fool February 25, 2008 Rick Aristotle Munarriz	Quick Take: The Sadness of Clean Fingers Print publications continue to suffer. Papers are closing down. Magazines are scaling back. And as battered as shares of print media moguls appear, analysts apparently feel that they are still overvalued.
The Motley Fool February 25, 2008 Rich Smith	Foolish Forecast: Ceradyne's Slip Is Showing In advance of earnings, analysts expect ceramics maker Ceradyne to barely grow sales, but profits may suffer.
The Motley Fool February 25, 2008 Rich Duprey	Foolish Forecast: Dollars Growing on Dollar Tree In advance of their earnings report, analysts don't expect to see any sales growth from Dollar Tree.
The Motley Fool February 25, 2008 Anders Bylund	Fat High-Tech Yields From Analog Devices Quarterly reports indicate Analog Devices seems to be coming out of a minor business realignment with a more focused product portfolio and a stronger operating blueprint.
The Motley Fool February 25, 2008 Rich Smith	Foolish Forecast: Sales Slip at Limited Brands In advance of the fashion retailer's earnings, analysts expect to see a drop in both sales and profits.
The Motley Fool February 25, 2008 Rick Aristotle Munarriz	4 Stocks That Took a Hike These companies recently raised their dividends: Coca-Cola... World Wrestling Entertainment... Nucor... Nordstrom...
The Motley Fool February 25, 2008 Brian Lawler	A Positive Surprise for Genentech Biopharma Genentech's lead drug gets a conditional OK to treat breast cancer.
The Motley Fool February 25, 2008 Brian Orelli	Look Across the Pond for Biosimilars Teva, ratiopharm, and CT Arzneimittel all get positive recommendations for their new biosimilars, as approvals for generic equivalents to biotech drugs are heating up in Europe.
The Motley Fool February 25, 2008 Christopher Barker	Terex Calms the Terrified Investor Equipment manufacturer Terex releases a staggeringly good report and forecasts global growth.
<Older 28841-28850 Newer> Return to current articles.